Tokyo, Japan

HyunJin Kim

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 5.5

ph-index = 2

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Inventor HyunJin Kim

Introduction:

HyunJin Kim, a brilliant inventor based in Tokyo, Japan, has made significant contributions to the field of biomedical technology. With a total of 4 patents to his name, Kim's cutting-edge research has focused on developing advanced solutions for delivering nucleic acids to targeted sites in patients.

Latest Patents:

1. Nucleic acid-loaded unit polyion complex: This patent unveils a unit-type polyion complex designed for efficient delivery of nucleic acids to specific locations in the human body. By utilizing a unique block copolymer with poly(ethylene glycol) and cationic poly(amino acid) segments, Kim's innovation ensures precise targeting and enhanced therapeutic outcomes.

2. Charge conversional ternary polyplex: Kim's pioneering work introduces a polymer composite (polyplex) containing nucleic acid, a cationic polymer, and an anionic polymer. This composite exhibits the ability to change its charge from negative to positive under acidic conditions, optimizing nucleic acid delivery in varying microenvironments.

Career Highlights:

HyunJin Kim has held key research positions at prestigious institutions, including The University of Tokyo and the Kawasaki Institute of Industrial Promotion. His innovative approach to biomedical technologies has garnered recognition and acclaim within the scientific community.

Collaborations:

Throughout his career, Kim has collaborated with esteemed colleagues such as Kanjiro Miyata and Kazunori Kataoka. Together, they have pushed the boundaries of nucleic acid delivery systems, paving the way for transformative advancements in personalized medicine.

Conclusion:

Inventor HyunJin Kim's relentless pursuit of innovation and his groundbreaking patents demonstrate his commitment to revolutionizing biomedical technology. Through his partnerships with leading researchers and his tenure at renowned institutions, Kim continues to shape the future of targeted drug delivery and precision medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…